Testing effectiveness (Phase 2)Enrolling By InvitationNCT03628612
What this trial is testing
Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells
Who this might be right for
Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell TherapyMultiple MyelomaDLBCL+2 more
Autolus Limited 500